The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-β (Aβ) deposition, tau hyperphosphorylation, oxidative stress, and chronic neuroinflammation. Growing evidence highlights neuroinflammation—driven by microglial activation and pro-inflamm...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Brain Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3425/15/5/485 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849327631162408960 |
|---|---|
| author | Joanna Kruszka Jakub Martyński Karolina Szewczyk-Golec Alina Woźniak Jarosław Nuszkiewicz |
| author_facet | Joanna Kruszka Jakub Martyński Karolina Szewczyk-Golec Alina Woźniak Jarosław Nuszkiewicz |
| author_sort | Joanna Kruszka |
| collection | DOAJ |
| description | Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-β (Aβ) deposition, tau hyperphosphorylation, oxidative stress, and chronic neuroinflammation. Growing evidence highlights neuroinflammation—driven by microglial activation and pro-inflammatory cytokine release—as a key contributor to AD pathogenesis and progression. In the absence of effective disease-modifying therapies, attention has turned to natural compounds with multi-target potential. Flavonoids, a diverse class of plant-derived polyphenols, have demonstrated neuroprotective properties through antioxidant activity, modulation of neuroinflammatory pathways, and interference with both Aβ aggregation and tau pathology. This narrative review provides an integrative overview of current findings on the mechanisms of action of key flavonoids—such as quercetin, luteolin, and apigenin—in both preclinical and clinical models. Emphasis is placed on their effects on microglial polarization, oxidative stress reduction, mitochondrial support, and synaptic function enhancement. Moreover, flavonoids show synergistic potential when combined with standard pharmacotherapies, such as acetylcholinesterase inhibitors, and may offer broader cognitive benefits in patients with mild cognitive impairment (MCI). Despite these promising findings, significant challenges persist, including poor bioavailability, inter-individual variability, and limited long-term clinical data. This review identifies critical gaps in knowledge and outlines future directions, including targeted drug delivery systems, biomarker-guided personalization, and long-duration trials. Flavonoids thus emerge not only as promising neuroprotective agents but also as complementary candidates in the development of future multi-modal strategies for AD treatment. |
| format | Article |
| id | doaj-art-36966aab06ba4fec8a536c3b3214d1a9 |
| institution | Kabale University |
| issn | 2076-3425 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Brain Sciences |
| spelling | doaj-art-36966aab06ba4fec8a536c3b3214d1a92025-08-20T03:47:49ZengMDPI AGBrain Sciences2076-34252025-05-0115548510.3390/brainsci15050485The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic PotentialJoanna Kruszka0Jakub Martyński1Karolina Szewczyk-Golec2Alina Woźniak3Jarosław Nuszkiewicz4Student Research Club of Medical Biology and Biochemistry, Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 24 Karłowicza St., 85-092 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 24 Karłowicza St., 85-092 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 24 Karłowicza St., 85-092 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 24 Karłowicza St., 85-092 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 24 Karłowicza St., 85-092 Bydgoszcz, PolandAlzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-β (Aβ) deposition, tau hyperphosphorylation, oxidative stress, and chronic neuroinflammation. Growing evidence highlights neuroinflammation—driven by microglial activation and pro-inflammatory cytokine release—as a key contributor to AD pathogenesis and progression. In the absence of effective disease-modifying therapies, attention has turned to natural compounds with multi-target potential. Flavonoids, a diverse class of plant-derived polyphenols, have demonstrated neuroprotective properties through antioxidant activity, modulation of neuroinflammatory pathways, and interference with both Aβ aggregation and tau pathology. This narrative review provides an integrative overview of current findings on the mechanisms of action of key flavonoids—such as quercetin, luteolin, and apigenin—in both preclinical and clinical models. Emphasis is placed on their effects on microglial polarization, oxidative stress reduction, mitochondrial support, and synaptic function enhancement. Moreover, flavonoids show synergistic potential when combined with standard pharmacotherapies, such as acetylcholinesterase inhibitors, and may offer broader cognitive benefits in patients with mild cognitive impairment (MCI). Despite these promising findings, significant challenges persist, including poor bioavailability, inter-individual variability, and limited long-term clinical data. This review identifies critical gaps in knowledge and outlines future directions, including targeted drug delivery systems, biomarker-guided personalization, and long-duration trials. Flavonoids thus emerge not only as promising neuroprotective agents but also as complementary candidates in the development of future multi-modal strategies for AD treatment.https://www.mdpi.com/2076-3425/15/5/485Alzheimer’s diseaseamyloid-βcognitive functionflavonoidsneuroinflammationneuroprotection |
| spellingShingle | Joanna Kruszka Jakub Martyński Karolina Szewczyk-Golec Alina Woźniak Jarosław Nuszkiewicz The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential Brain Sciences Alzheimer’s disease amyloid-β cognitive function flavonoids neuroinflammation neuroprotection |
| title | The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential |
| title_full | The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential |
| title_fullStr | The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential |
| title_full_unstemmed | The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential |
| title_short | The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential |
| title_sort | role of selected flavonoids in modulating neuroinflammation in alzheimer s disease mechanisms and therapeutic potential |
| topic | Alzheimer’s disease amyloid-β cognitive function flavonoids neuroinflammation neuroprotection |
| url | https://www.mdpi.com/2076-3425/15/5/485 |
| work_keys_str_mv | AT joannakruszka theroleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT jakubmartynski theroleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT karolinaszewczykgolec theroleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT alinawozniak theroleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT jarosławnuszkiewicz theroleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT joannakruszka roleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT jakubmartynski roleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT karolinaszewczykgolec roleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT alinawozniak roleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential AT jarosławnuszkiewicz roleofselectedflavonoidsinmodulatingneuroinflammationinalzheimersdiseasemechanismsandtherapeuticpotential |